# John G. Golfinos

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-g-golfinos/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,360 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 55 |
| i10-index | 148 |
| Last Known Institution | NYU Langone Health |
| OpenAlex ID | https://openalex.org/A5021588104 |
| ORCID iD | 0000-0003-4221-0180 |
| Works | 378 |

## Researcher papers

- [The natural history of familial cavernous malformations: results of an ongoing study](https://scholariq.org/papers/the-natural-history-of-familial-cavernous-malformations-results-of-an-ongoing/)
- [Transforming Fusions of <i>FGFR</i> and <i>TACC</i> Genes in Human Glioblastoma](https://scholariq.org/papers/transforming-fusions-of-i-fgfr-i-and-i-tacc-i-genes-in-human-glioblastoma/)
- [Glial Neoplasms: Dynamic Contrast-enhanced T2*-weighted MR Imaging](https://scholariq.org/papers/glial-neoplasms-dynamic-contrast-enhanced-t2-weighted-mr-imaging/)
- [Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging](https://scholariq.org/papers/gliomas-predicting-time-to-progression-or-survival-with-cerebral-blood-volume/)
- [Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.](https://scholariq.org/papers/comparison-of-cerebral-blood-volume-and-vascular-permeability-from-dynamic/)
- [T2–FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project](https://scholariq.org/papers/t2-flair-mismatch-an-imaging-biomarker-for-idh-and-1p-19q-status-in-lower-grade/)
- [Clinical use of a frameless stereotactic arm: results of 325 cases](https://scholariq.org/papers/clinical-use-of-a-frameless-stereotactic-arm-results-of-325-cases/)
- [Domain-specific impairment in metacognitive accuracy following anterior prefrontal lesions](https://scholariq.org/papers/domain-specific-impairment-in-metacognitive-accuracy-following-anterior/)
- [Mutant IDH1 and seizures in patients with glioma](https://scholariq.org/papers/mutant-idh1-and-seizures-in-patients-with-glioma/)
- [Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival](https://scholariq.org/papers/antiangiogenic-therapy-using-bevacizumab-in-recurrent-high-grade-glioma-impact/)
- [A Multicenter, Single-Blind, Prospective Randomized Trial to Evaluate the Safety of a Polyethylene Glycol Hydrogel (Duraseal Dural Sealant System) as a Dural Sealant in Cranial Surgery](https://scholariq.org/papers/a-multicenter-single-blind-prospective-randomized-trial-to-evaluate-the-safety/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Meningioma and schwannoma management](https://scholariq.org/topics/meningioma-and-schwannoma-management/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Neurofibromatosis and Schwannoma Cases](https://scholariq.org/topics/neurofibromatosis-and-schwannoma-cases/)
- [Head and Neck Surgical Oncology](https://scholariq.org/topics/head-and-neck-surgical-oncology/)

## Researcher university

- [NYU Langone Health](https://scholariq.org/institutions/nyu-langone-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
